Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Ladostigil hemitartrate (TV-3326) is a compound that acts as a dual inhibitor of cholinesterase and brain-selective monoamine oxidase (MAO). It has IC50 values of 37.1 μM for MAO-B and 31.8 μM for AChE. In addition, Ladostigil hemitartrate possesses neuroprotective, antioxidant, and anti-inflammatory properties. It is commonly used in research relating to depression and Alzheimer's disease.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
2 mg | 5 days | $ 198.00 | |
5 mg | 5 days | $ 386.00 |
Description | Ladostigil hemitartrate (TV-3326) is a compound that acts as a dual inhibitor of cholinesterase and brain-selective monoamine oxidase (MAO). It has IC50 values of 37.1 μM for MAO-B and 31.8 μM for AChE. In addition, Ladostigil hemitartrate possesses neuroprotective, antioxidant, and anti-inflammatory properties. It is commonly used in research relating to depression and Alzheimer's disease. |
Targets&IC50 | MAO-B:37.1 nM (IC50), AChE:31.8 nM (IC50) |
In vitro | Ladostigil hemitartrate (1-10 μM) demonstrates significant neuroprotective properties by preventing the decrease of mitochondrial membrane potential (ψ), attenuating apoptotic cascades, and inhibiting ROS production triggered by oxidative stress (OS) insults[2]. Additionally, it inhibits caspase-3 activation, upregulates Bcl-2, and decreases Bad and Bax gene and protein expression in human neuroblastoma SK-N-SH cells[2]. |
In vivo | Ladostigil hemitartrate, administered orally at 17 mg/kg daily for six weeks, effectively eliminates hyperanxiety and depressive-like behaviors in Sprague-Dawley rats, observed through the elevated plus maze (EPM) and forced swim tests (FST) from puberty into adulthood. This treatment regimen notably inhibited brain monoamine oxidase A and B (MAO-A and B) activity by over 60% and mitigated the heightened anxiety and depressive symptoms in both male and female rats prenatally stressed (PS). Additionally, a single oral dose of Ladostigil hemitartrate at 50 μmol/kg was sufficient to reverse episodic memory loss in the object recognition test in rats, showcasing its potential therapeutic effects on memory impairments. |
Synonyms | TV-3326 hemitartrate, Ladostigil hemitartrate |
Molecular Weight | 422.434 |
Formula | C20H26N2O8 |
CAS No. | 209394-46-7 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Ladostigil hemitartrate 209394-46-7 TV 3326 Hemitartrate Ladostigil Hemitartrate TV-3326 Hemitartrate TV-3326 hemitartrate TV3326 TV 3326 TV3326 Hemitartrate Ladostigil TV-3326 inhibitor inhibit